1. Home
  2. EU vs IRWD Comparison

EU vs IRWD Comparison

Compare EU & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$2.64

Market Cap

464.5M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.54

Market Cap

520.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EU
IRWD
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
464.5M
520.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
EU
IRWD
Price
$2.64
$4.54
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$4.00
$5.34
AVG Volume (30 Days)
2.9M
2.3M
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
$44,142,000.00
$338,987,000.00
Revenue This Year
$17.41
N/A
Revenue Next Year
$95.45
$4.01
P/E Ratio
N/A
$19.03
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.53
52 Week High
$4.19
$4.78

Technical Indicators

Market Signals
Indicator
EU
IRWD
Relative Strength Index (RSI) 52.01 78.52
Support Level $2.35 $3.11
Resistance Level $2.54 $3.39
Average True Range (ATR) 0.18 0.29
MACD 0.01 0.03
Stochastic Oscillator 64.60 55.37

Price Performance

Historical Comparison
EU
IRWD

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: